Headline News about AbbVie![]() ![]() ![]() ![]()
AbbVie's New $9B Neuroscience Space Deal Might Attract FTC Scrutiny, Analyst Signals
December 07, 2023
Via Benzinga
![]()
Why Cerevel Therapeutics Stock Is Higher
December 07, 2023
Via Benzinga
![]()
Is AbbVie Stock a Buy Now?
December 07, 2023
Via The Motley Fool
![]()
Decoding AbbVie's Options Activity: What's the Big Picture?
December 05, 2023
Via Benzinga
![]()
Analyst Ratings for AbbVie
December 01, 2023
Via Benzinga
![]()
Health Care Company AbbVie Announces Acquisition of Immunogen
November 30, 2023
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
AbbVie's Big Buy Of ImmunoGen Opens Doors For Potential Investment Gains
December 04, 2023
Via Talk Markets
![]() ![]()
5 S&P 500 Stocks That Pay a Generous Dividend
December 02, 2023
Via The Motley Fool
Topics
Stocks
Exposures
US Equities
![]() ![]() ![]() ![]() Via Benzinga
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|